Charterhouse Invests in Skin Tech Pharma Group

June 21, 2024

Charterhouse Capital Partners has announced an investment in Skin Tech Pharma Group, a Spain-headquartered medical aesthetics manufacturer founded by Dr Philippe Deprez. The partnership will support Skin Tech’s organic growth (product innovation and market entry) and pursue inorganic expansion through targeted M&A while the founder is re-investing in the business.

Buyers
Charterhouse Capital Partners
Targets
Skin Tech Pharma Group
Industry
Medical Devices
Location
Catalonia, Spain
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.